|
TP53BP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.689800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.400000E-01 |
| Normal-vs-Stage2 |
7.333000E-01 |
| Normal-vs-Stage3 |
7.991000E-01 |
| Normal-vs-Stage4 |
6.223400E-01 |
| Stage1-vs-Stage2 |
3.917200E-01 |
| Stage1-vs-Stage3 |
3.918200E-01 |
| Stage1-vs-Stage4 |
9.578200E-01 |
| Stage2-vs-Stage3 |
9.330600E-01 |
| Stage2-vs-Stage4 |
5.588400E-01 |
| Stage3-vs-Stage4 |
5.904800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.864800E-01 |
| Normal-vs-AfricanAmerican |
7.454200E-01 |
| Normal-vs-Asian |
5.642200E-01 |
| Caucasian-vs-AfricanAmerican |
5.599000E-01 |
| Caucasian-vs-Asian |
6.827000E-01 |
| AfricanAmerican-vs-Asian |
5.319600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.997600E-01 |
| Normal-vs-Female |
8.015700E-03 |
| Male-vs-Female |
4.10740000000853E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.648000E-01 |
| Normal-vs-Extreme_Weight |
1.862750E-01 |
| Normal-vs-Obese |
8.458600E-01 |
| Normal-vs-Extreme_Obese |
8.669000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.305000E-01 |
| Normal_Weight-vs-Obese |
7.996800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.631800E-01 |
| Extreme_Weight-vs-Obese |
1.071440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.946200E-01 |
| Obese-vs-Extreme_Obese |
9.807200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.295600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.644600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.468400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.896000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.520000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.305000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.397910E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.234000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.020200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.117600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.240400E-01 |
| Normal-VS-Type2 PRCC |
7.226000E-01 |
| Normal-VS-KIRP CIMP |
8.356000E-01 |
| Normal-VS-Unclassified PRCC |
2.426800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.481800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.304200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.694200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.625600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.134650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.989800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.903630E-01 |
| Normal-vs-N1 |
6.279400E-01 |
| Normal-vs-N2 |
8.460000E-01 |
| N0-vs-N1 |
1.717030E-01 |
| N0-vs-N2 |
7.053000E-01 |
| N1-vs-N2 |
7.310000E-01 |
|
|
